Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Yichi Su
Pharmacodynamics of Akt drugs revealed by a kinase-modulated bioluminescent indicator - Nature Chemical Biology
Abstract Measuring pharmacodynamics (PD)—the biochemical effects of drug dosing—and correlating them with therapeutic efficacy in animal models is crucial for the development of effective drugs but traditional PD studies are labor and resource intensive. Here we developed a kinase-modulated bioluminescent indicator (KiMBI) for rapid, noninvasive PD assessment of Akt-targeted drugs, minimizing drug and animal use.
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations
Research Article CORONAVIRUS Michael Westberg https://orcid.org/0000-0002-2312-5282 westberg@chem.au.dk, Yichi Su https://orcid.org/0000-0001-5715-835X, [...] , Xinzhi Zou https://orcid.org/0000-0002-3382-2401, Pinghan Huang https://orcid.org/0000-0003-2460-0695, [...] , Arjun Rustagi https://orcid.org/0000-0002-6921-1012, Jaishree Garhyan https://orcid.org/0000-0002-1657-8320, Puja Bhavesh Patel, Daniel Fernandez https://orcid.org/0000-0002-6221-152X, Yan Wu...
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations
Supplementary Materials Materials and Methods Figs. S1 to S24 Tables S1 to S8 MDAR Reproducibility Checklist REFERENCES AND NOTES 1 WHO, “COVID-19 Weekly Epidemiological Update - 29 September 2023” (2023). 2 M. W. Tenforde, W. H. Self, M. Gaglani, A. A. Ginde, D. J. Douin, H. K. Talbot, J. D. Casey, N. M. Mohr, A. Zepeski, T. McNeal, S. Ghamande, K. W. Gibbs, D. C. Files, D. N. Hager, A. Shehu, M. E. Prekker, A. E. Frosch, M. N. Gong, A. Mohamed, N. J. Johnson, V. Srinivasan, J. S. Steingrub, I. D. Peltan, S. M. Brown, E. T. Martin, A. S.
Design of SARS-CoV-2 protease inhibitors with improved affinity and reduced sensitivity to mutations
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
An optimized bioluminescent substrate for non-invasive imaging in the brain - Nature Chemical Biology
Abstract Bioluminescence imaging (BLI) allows non-invasive visualization of cells and biochemical events in vivo and thus has become an indispensable technique in biomedical research. However, BLI in the central nervous system remains challenging because luciferases show relatively poor performance in the brain with existing substrates. Here, we report the discovery of a NanoLuc substrate with improved brain performance, cephalofurimazine (CFz).
Novel NanoLuc substrates enable bright two-population bioluminescence imaging in animals
Abstract Sensitive detection of two biological events in vivo has long been a goal in bioluminescence imaging. Antares, a fusion of the luciferase NanoLuc to the orange fluorescent protein CyOFP, has emerged as a bright bioluminescent reporter with orthogonal substrate specificity to firefly luciferase (FLuc) and its derivatives such as AkaLuc. However, the brightness of Antares in mice is limited by the poor solubility and bioavailability of the NanoLuc substrate furimazine.
In Vitro and In Vivo Enzyme Activity Screening via RNA-Based Fluorescent Biosensors for S-Adenosyl-l-homocysteine (SAH)
High-throughput enzyme activity screens are essential for target characterization and drug development, but few assays employ techniques or reagents that are applicable to both in vitro and live cell settings. Here, we present a class of selective and sensitive fluorescent biosensors for S-adenosyl-l-homocysteine (SAH) that provide a direct “mix and go” activity assay for methyltransferases (MTases), an enzyme class that includes several cancer therapeutic targets.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Yichi
Contact Yichi, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack